BioTech Pharma
DSIP research vial

2D Molecular Structure

DSIP 2D molecular structure for compound 68816
CID
68816
Standard InChIKey
ZRZROXNBKJAOKB-GFVHOAGBSA-N
FDA UNII
YN28Z5YZ73
Residue Count
9 AA
Structural Modifications
  • Free N-terminus
  • Free C-terminal acid
  • No disulfide bonds
cognitive Research

DSIP

Also known as: Delta Sleep-Inducing Peptide, Emideltide

Nine-residue neuropeptide first characterized for delta-wave EEG activity, studied in sleep-architecture and stress-response research.
CAS Number
62568-57-4
Molecular Formula
C35H48N10O15
Molecular Weight
848.8 g/mol
Purity
Batch-specific
Form
Lyophilized powder
Enquiry Sizes
Research vial • Bulk / custom fill (quote required)
Peptide Sequence9 residues
Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

Compliance Notice: All products supplied by BioTech Pharma are intended strictly for laboratory research and development use only. They are not intended for human or veterinary use, diagnosis, treatment, or consumption of any kind. By submitting an enquiry, the requester confirms they are a qualified researcher or institution and accepts full responsibility for compliant handling and use.

Configure Your Request

Documentation requests are reviewed against the records available for the applicable lot. Availability, methods, and values must be confirmed for the specific enquiry and are not promised in advance.

Form supplied: Lyophilized powder. Your selections are carried into the quote request automatically.

Overview

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, originally isolated from cerebral venous blood in studies of sleep-related electrophysiology. Its name derives from early reports associating the peptide with delta-wave EEG activity in animal models.

Preclinical literature has investigated DSIP in relation to sleep architecture, the hypothalamic–pituitary–adrenal stress axis, and neuromodulatory signaling. These findings are exploratory: DSIP has no established pharmacology or approved therapeutic role, and reported effects vary across experimental systems, so results should be treated as preliminary rather than settled mechanism.

BioTech Pharma supplies DSIP as a lyophilized powder for in-vitro and preclinical research use only. Lot-specific analytical documentation may be available and should be confirmed for the applicable material.

Research Applications

  • Sleep-architecture and EEG neuromodulation models
  • Hypothalamic–pituitary–adrenal (HPA) stress-axis research
  • Neuropeptide receptor and signaling studies
  • Peptide stability and analytical method development

Frequently Asked Questions

Scientific References

Analytical Data

Lot-specific documentation may be available for the applicable material and must be confirmed per enquiry. Where available, it may include:

  • HPLC purity result
  • LC-MS identity confirmation
  • Appearance
  • Net content

Request the records you need with your quote and we will confirm availability for your batch.

Procurement Details

Availability, lead time, salt / content basis, and cold-chain requirements depend on the specific lot and quantity, so we confirm them per enquiry rather than publishing fixed figures. Request confirmation for your requirements with your quote and our team will respond with details for the applicable batch.

Storage & Handling

Lyophilized: store at −20 °C, protected from light and moisture. Reconstituted: store cold and protected from light; verify prepared-solution stability for the applicable material before extended use.

Related Compounds